High mRNA expression of the fast cycling and constitutively active RAC1b isoform does not predict ovarian cancer patient survival and trended toward higher survival probability (Figure 6D [113,120,121,122,129,130,155]); the finding was consistent irrespective of various groupings, treatment as a continuous variable or when expressed as a fraction of total RAC1 mRNA expression. This evidence concerns the gene RAC1 and ovarian cancer.